Danville, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Beyond Antibiotics, founded in 2018, is a small nonprofit in the Medical Research sector that reported $350K in total revenue in fiscal year 2023. Revenue surged 990% from the prior year, signaling strong growth momentum. The organization ran a surplus of $141K, a strong 40% operating margin.
Beyond Antibiotics is dedicated to advancing research in the area of compounds, such as antimicrobial or antimicrobial-like substances, and other efforts that prevent and protect against infectious diseases and improve overall human and animal health.
Research on solutions for prevention and treatment of COVID19. Dealt pricinply with a novel synthetic new patented molecule that was discovered to kill lipid-envelope viruses like COVID 19, in...
Research on solutions for prevention and treatment of COVID19. Dealt pricinply with a novel synthetic new patented molecule that was discovered to kill lipid-envelope viruses like COVID 19, in addition to its antimicrobial, fungicidal and yeast killing attributes.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $350,000 | $32,118 | +9.9% |
| Expenses | $209,406 | $65,236 | +2.2% |
| Net Income | $140,594 | $-33,118 | -5.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| William E Brown | President | 2.00 |
Officer
|
$0 | $0 | $0 |
| Jill DeMichiel | Sec/Treas | 2.00 |
Officer
|
$0 | $0 | $0 |
| Sharon Bonner-Brown | Director | 2.00 |
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2023 | $350,000 | $209,406 | $328,394 | $140,594 |
| 2021 | $200,000 | $217,466 | $207,174 | $-17,466 |
| 2020 | $405,000 | $189,941 | $224,640 | $215,059 |
Compare Beyond Antibiotics with other nonprofits in California and across the country.